BioGenCell

Two scientists working in a research laboratory
#BioGenCell #Clinical trial #Collaboration #Diabetes #Partnership #Phase II trial #University of California San Francisco

Industry-academia alliance targets chronic limb-threatening ischaemia

BioGenCell has partnered with the University of California San Francisco (UCSF) as part of the company’s Phase II clinical trials. The partnership will focus on the impact of BioGenCell’s treatment on those with chronic limb-threatening ischaemia (CLTI also known as CLI), a debilitating condition commonly associated… Read More

#News